21 May 2013
Keywords: strong, ph, iii, data, herceptin, stomach, cancer
Article | 23 March 2009
Swiss drug major Roche says results from a large Phase III study show that adding Herceptin (trastuzumab) to standard chemotherapy
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 March 2009
20 May 2013
© 2013 thepharmaletter.com